Product category:
Microbiology
News Release from: Warnex
Edited by the Laboratorytalk Editorial
Team on 05 September 2006
Warnex concludes acquisition of MDS
Pharma
Warnex Analytical Services has concluded the acquisition of the MDS Pharma Services pharmaceutics business located in Blainville, Quebec, following an agreement in principle announced on 18 July 2006
The purchase price of $1,950,112.23 was paid in cash Concurrent to the acquisition, Warnex signed a 12-month lease for the Blainville facilities, with an option to renew for six months
This article was originally published on Laboratorytalk on 21 Mar 2006 at 8.00am (UK)
Related stories
Quantitative PCR test for food testing
Warnex has announced the launch of a quantitative test for Campylobacter for use with the real-time PCR-based Warnex rapid pathogen detection system
Warnex signs up US service lab, AmeriSci Bio-Chem
AmeriSci Bio-Chem, a leading scientific service laboratory based in Midlothian, Virginia, will offer real-time PCR pathogen testing services using the Warnex rapid pathogen detection system
The acquisition will operate as Neopharm Laboratories, a division of Warnex Analytical Services.
Warnex expects to bring the Blainville pharmaceutics operations, which reported $6.7 million in annual revenue and incurred a loss in its last fiscal year, in line with the historically profitable performance of its existing analytical business unit.
The acquisition, which effectively doubles the company's analytical revenue, is expected to be Ebitda positive within 12 months.
"This acquisition, for a number of reasons, made sound, strategic rationale.
"First, we are already well established in this business segment and this acquisition gave us a one time opportunity to leverage our success into a dominant market position in our regional market of Quebec," said Mark Busgang, president and CEO of Warnex.
"As well, this acquisition gives us the scale to reach beyond our regional market and we will now focus on more aggressive international growth".
MDS Pharma Services's analytical laboratories offer pharmaceutical analysis, traditional chemistry, microbiology, method development and validation, technology transfer, and stability studies.
The Blainville operations occupy 28,000 square feet and are fully cGMP compliant.
The MDS Pharma Services Bioanalytical Services unit continues its operations at the Blainville site.
• Warnex: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
